| Sep 21 |
United Therapeutics (UTHR) Is Thriving on Strong Demand and Smart Pricing
|
| Sep 16 |
Liquidia Says United Therapeutics' Interference Found by US Court to Have Caused Losses of Over $137 Million
|
| Sep 16 |
Strength Seen in Foghorn Therapeutics (FHTX): Can Its 9.5% Jump Turn into More Strength?
|
| Sep 10 |
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
|
| Aug 30 |
United Therapeutics Shares Thrive
|
| Aug 30 |
United Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue?
|
| Aug 28 |
Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity
|
| Aug 28 |
United Therapeutics Corporation's (NASDAQ:UTHR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
|
| Aug 28 |
United Therapeutics Corporation to Present at Upcoming Investor Conferences
|
| Aug 20 |
Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval
|
